Analysis Of Chronic Kidney Diseases Patients With CAPD (Continuous Ambulatory Peritoneal Dialysis) And Hemodialysis Reviewed From Kidney Function (Ureum And Kreatinin)

  • Sutrisno Sutrisno STIKes Surya Mitra Husada Kediri
  • Alfian Fawzi STIKes Surya Mitra Husada Kediri
Keywords: kidney failure, Hemodialisys, CAPD


Dialysis is a therapy that aims to remove waste and excess fluid from the body. This method replaces the main function of the kidney. Two types of dialysis are known, namely Peritoneal Dialysis and Hemodialysis. Patients with chronic kidney failure are faced with these two treatment options. Both types of dialysis therapy have a risk of complications during the treatment period that can affect the quality of life of patients. The purpose of this study was to determine the differences in dialysis methods of patients with chronic kidney failure with CAPD (continuous ambulatory peritoneal dialysis) and hemodialysis in terms of kidney function (urea and creatinine).The research design used a cross-sectional comparative analytical research design. The independent variables were the action of hemodialysis and CAPD. The dependent variables were urea and creatinine. The study sample was patients with chronic kidney failure who underwent hemodialysis and CAPD at Saiful Anwar Hospital in Malang with 126 respondents using consecutive sampling technique. Data analyzed by Independent T-test (a = 0.05). The research instruments were laboratory urea and creatinine observation sheets.Respondents who received hemodialysis were 23 patients. The average value of  respondents who underwent HD was equal to (12.93 ± 4.53) mg / dL and the average value of urea could be obtained at (144.89 ± 44.73) mg / dL. Respondents who received CAPD actions amounted to 20 patients. The average value of respondents who underwent CAPD was equal to (10.32 ± 4.1) mg / dL and the average value of urea could be obtained at (104.18 ± 48.2) mg / dL. There were no differences in kidney function in patients who received HD and CAPD (creatinine p value = 0.130; urea p value = 0.083).


Download data is not yet available.


[1] Aness, M. (2011). Dialysis-related factors affecting quality of life in patients on hemodialysis. Iranian Journal of Kidney Diseases, 5, 9-14
[2] Black, J.M., & Hawks, J.H. (2009). Medical surgical nursing: Clinical management for positive outcomes (8th ed) Elsevier. Inc.
[3] Druce, T.B., et al. (2006). Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med. 355, 2071-84
[4] Foley, R.N., Curtis, B.M., & Parfrey, P.S. (2009). Erythropoietin therapy, hemoglobin targets, and quality of life in healthy hemodialysis patients: A randomized trial. Clin J Am Soc Nephrol, 4, 726-733.
[5] Kallenbach, J.Z., Gutch, C.F. Martha, S.H., & Corca, A.L. (2005). Review of hemodialysis for nurse and dialysis personel (7 th ed.). St. Louis : Elsevier Mosby.
[6] Lewis, S.L., et al. (2011). Medical surgical nursing: Assessment and management of clinical problems (8th ed). Elsevier. Inc.
[7] Price, S.A. & Wilson, L.M. (1995). Patofisiologi konsep klinis proses-proses penyakit. Jakarta: EGC.
[8] Snyder, J.J., (2004). Hemoglobin levels and erythropoietin doses in hemodialysis and peritoneal dialysis patients in the United States. J Am Soc Nephrol. 15, 174–179
[9] Wyss, M., & Daouk, R.K. (2000). Creatine and creatinine metabolism, physiological Reviews. Vol. 80, No. 3, July 2000.
[10] Yamana, E. (2009). The relationship of clinical laboratory parameters and patient attributes to the quality of life of patients on hemodialysis. Japan Journal of Nursing Science, 6, 9–20.